NSL literature pointer PMID 24413708 L-Carnitine laboratory index [PMID: 24413708] National Science Labs indexing note for PMID 24413708: review the PubMed methods, models, and limitations before citing
As a result, eating a restrictive diet, such as a strict vegetarian or vegan diet, can lead to B12 deficiency
Formulated by Shelena Lalji, M.D., the founder and medical director of the Dr
Semaglutide in Bloomfield Michigan A guide that allows you to explore available options in your area By Dr
High levels of AGEs have been found to accelerate not only the process of skin aging, but also the vascular aging and the development of neurodegenerative diseases [27, 28]

| Category | Zepbound | Mounjaro | |-----------------------------------|------------------------------------------------|------------------------------------------------| | FDA Approval Indication | Obesity and overweight management (with comorbidities) | Type 2 diabetes management | | Year of FDA Approval | 2023 | 2022 | | Active Ingredient | Tirzepatide | Tirzepatide | | Dose Range | 2.5 mg to 15 mg once weekly | 2.5 mg to 15 mg once weekly | | Primary Clinical Purpose | Weight loss | Blood sugar control | | GLP-1/GIP Activity | Dual agonist (GLP-1 + GIP) | Dual agonist (GLP-1 + GIP) | | Average Weight Loss (in trials) | Up to 22.5% of body weight in SURMOUNT-1 study | Up to 15% of body weight in SURPASS studies | | Insulin Sensitivity Impact | Improves insulin sensitivity in patients with obesity | Improves insulin sensitivity in type 2 diabetes patients | | Delivery Method | Single-use auto-injector pen, subcutaneous injection | Single-use auto-injector pen, subcutaneous injection | | Dosing Frequency | Once weekly | Once weekly | | Manufacturer | Eli Lilly | Eli Lilly | | Common Side Effects | Nausea, vomiting, diarrhea, constipation, decreased appetite | Nausea, vomiting, diarrhea, constipation, decreased appetite | | Insurance Coverage | Variable
